592 related articles for article (PubMed ID: 27475796)
1. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use.
Schmerber S; Deguine O; Marx M; Van de Heyning P; Sterkers O; Mosnier I; Garin P; Godey B; Vincent C; Venail F; Mondain M; Deveze A; Lavieille JP; Karkas A
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1835-1851. PubMed ID: 27475796
[TBL] [Abstract][Full Text] [Related]
2. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
Sprinzl G; Toner J; Koitschev A; Berger N; Keintzel T; Rasse T; Baumgartner WD; Honeder C; Magele A; Plontke S; Götze G; Schmutzhard J; Zelger P; Corkill S; Lenarz T; Salcher R
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1565-1579. PubMed ID: 36625869
[TBL] [Abstract][Full Text] [Related]
3. A New Transcutaneous Bone Conduction Hearing Implant: Short-term Safety and Efficacy in Children.
Baumgartner WD; Hamzavi JS; Böheim K; Wolf-Magele A; Schlögel M; Riechelmann H; Zorowka P; Koci V; Keck T; Potzinger P; Sprinzl G
Otol Neurotol; 2016 Jul; 37(6):713-20. PubMed ID: 27153327
[TBL] [Abstract][Full Text] [Related]
4. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study.
den Besten CA; Monksfield P; Bosman A; Skarzynski PH; Green K; Runge C; Wigren S; Blechert JI; Flynn MC; Mylanus EAM; Hol MKS
Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920
[TBL] [Abstract][Full Text] [Related]
5. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes.
Cywka KB; Skarzynski PH; Krol B; Hatzopoulos S; Skarzynski H
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3525-3534. PubMed ID: 35182185
[TBL] [Abstract][Full Text] [Related]
7. An experimental objective method to determine maximum output and dynamic range of an active bone conduction implant: the Bonebridge.
Mertens G; Desmet J; Snik AF; Van de Heyning P
Otol Neurotol; 2014 Aug; 35(7):1126-30. PubMed ID: 24662632
[TBL] [Abstract][Full Text] [Related]
8. Objective and subjective results of the Bonebridge transcutaneous active direct-drive bone conduction hearing implant.
Alzhrani F
Saudi Med J; 2019 Aug; 40(8):797-801. PubMed ID: 31423516
[TBL] [Abstract][Full Text] [Related]
9. Outcomes after Application of Active Bone Conducting Implants.
Koro E; Werner M
Audiol Neurootol; 2019; 24(4):197-205. PubMed ID: 31499490
[TBL] [Abstract][Full Text] [Related]
10. The Bonebridge implant in older children and adolescents with mixed or conductive hearing loss: Audiological outcomes.
Ratuszniak A; Skarzynski PH; Gos E; Skarzynski H
Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():97-102. PubMed ID: 30599287
[TBL] [Abstract][Full Text] [Related]
11. A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness.
Willenborg K; Avallone E; Maier H; Lenarz T; Busch S
Audiol Neurootol; 2022; 27(1):83-92. PubMed ID: 33902037
[TBL] [Abstract][Full Text] [Related]
12. The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature.
Sprinzl GM; Wolf-Magele A
Clin Otolaryngol; 2016 Apr; 41(2):131-43. PubMed ID: 26073720
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss.
Gerdes T; Salcher RB; Schwab B; Lenarz T; Maier H
Otol Neurotol; 2016 Jul; 37(6):685-91. PubMed ID: 27093021
[TBL] [Abstract][Full Text] [Related]
14. Hearing Benefit and Rated Satisfaction in Children with Unilateral Conductive Hearing Loss Using a Transcutaneous Magnetic-Coupled Bone-Conduction Hearing Aid.
Polonenko MJ; Carinci L; Gordon KA; Papsin BC; Cushing SL
J Am Acad Audiol; 2016; 27(10):790-804. PubMed ID: 27885975
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous bone-conduction hearing device: audiological and surgical aspects in a first series of patients with mixed hearing loss.
Barbara M; Perotti M; Gioia B; Volpini L; Monini S
Acta Otolaryngol; 2013 Oct; 133(10):1058-64. PubMed ID: 23768011
[TBL] [Abstract][Full Text] [Related]
16. Audiologic, surgical and subjective outcomes of active transcutaneous bone conduction implant system (Bonebridge).
Oh SJ; Goh EK; Choi SW; Lee S; Lee HM; Lee IW; Kong SK
Int J Audiol; 2019 Dec; 58(12):956-963. PubMed ID: 31460815
[No Abstract] [Full Text] [Related]
17. The Sophono bone-conduction system: Surgical, audiologic, and quality-of-life outcomes.
Mclean T; Pai I; Philipatos A; Gordon M
Ear Nose Throat J; 2017 Jul; 96(7):E28-E33. PubMed ID: 28719716
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous bone conductive implants in patients with conductive/mixed hearing loss: audiological outcomes in noise condition.
Magliulo G; Iannella G; De Vincentiis M; Turchetta R; Portanova G; Angeletti D; Mancini P
Acta Otolaryngol; 2018 Sep; 138(9):822-829. PubMed ID: 29939073
[TBL] [Abstract][Full Text] [Related]
19. Individualised headband simulation test for predicting outcome after percutaneous bone conductive implantation.
Monini S; Filippi C; Atturo F; Biagini M; Lazzarino AI; Barbara M
Acta Otorhinolaryngol Ital; 2015 Oct; 35(4):258-64. PubMed ID: 26824212
[TBL] [Abstract][Full Text] [Related]
20. Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant.
Riss D; Arnoldner C; Baumgartner WD; Blineder M; Flak S; Bachner A; Gstoettner W; Hamzavi JS
Laryngoscope; 2014 Dec; 124(12):2802-6. PubMed ID: 25142577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
